Ciclosporin/lansoprazole - Perle Biosciences
Alternative Names: Lansoprazole/ciclosporin - Perle BiosciencesLatest Information Update: 16 Jul 2016
At a glance
- Originator Perle Bioscience
- Class Antihyperglycaemics; Benzimidazoles; Ciclosporins; Gastric antisecretories; Pyridines; Small molecules; Sulfoxides
- Mechanism of Action Calcineurin inhibitors; Free radical inhibitors; Immunosuppressants; Mitochondrial permeability transition pore inhibitors; P-glycoprotein inhibitors; Proton pump inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- No development reported Type 1 diabetes mellitus
Most Recent Events
- 16 Jul 2016 No recent reports of development identified for preclinical development in Type-1 diabetes mellitus in USA (PO)
- 17 Apr 2016 Perle Bioscience withdraws a phase III trial for Type 1 diabetes mellitus (In Children, In adolescents, In adults) in USA (NCT01762657)
- 02 Jan 2013 Preclinical trials in Type-1 diabetes mellitus in USA (PO)